These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31170519)

  • 1. Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation.
    Abdelhakim H; Shune L; Bhatti S; Cantilena AR; Baran A; Lin TL; Ganguly S; Singh AK; Abhyankar S; Divine C; Lipe B; McGuirk J; Allin D; Aljitawi OS
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1713-1719. PubMed ID: 31170519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment.
    Mina A; Shune L; Abdelhakim H; Lin TL; Ganguly S; Baran A; Singh A; Abhyankar S; McGuirk JP; Allin D; Aljitawi OS
    Ann Hematol; 2019 Feb; 98(2):481-489. PubMed ID: 30382305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
    Cioch M; Jawniak D; Kotwica K; Wach M; Mańko J; Gorący A; Klimek P; Mazurkiewicz E; Jarosz P; Hus M
    Transplant Proc; 2014 Oct; 46(8):2882-4. PubMed ID: 25380941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
    Singh AD; Parmar S; Patel K; Shah S; Shore T; Gergis U; Mayer S; Phillips A; Hsu JM; Niesvizky R; Mark TM; Pearse R; Rossi A; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):288-293. PubMed ID: 29061534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.
    Solh M; Brunstein C; Morgan S; Weisdorf D
    Biol Blood Marrow Transplant; 2011 May; 17(5):710-6. PubMed ID: 20813199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbaric oxygen treatment effects on in vitro cultured umbilical cord blood CD34
    Cheung KY; Berry A; Li D; Aljitawi OS
    Cytotherapy; 2018 Jan; 20(1):87-94. PubMed ID: 29037940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.
    Aljitawi OS; Xiao Y; Eskew JD; Parelkar NK; Swink M; Radel J; Lin TL; Kimler BF; Mahnken JD; McGuirk JP; Broxmeyer HE; Vielhauer G
    Blood Cells Mol Dis; 2014 Jan; 52(1):59-67. PubMed ID: 23953010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.
    Grosso D; Leiby B; Wilde L; Carabasi M; Filicko-O'Hara J; O'Hara W; Wagner JL; Mateja G; Alpdogan O; Binder A; Kasner M; Keiffer G; Klumpp T; Martinez UO; Palmisiano N; Porcu P; Gergis U; Flomenberg N
    Transplant Cell Ther; 2022 Dec; 28(12):831.e1-831.e7. PubMed ID: 36167307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation.
    Fernandez HF; Tran HT; Albrecht F; Lennon S; Caldera H; Goodman MS
    Biol Blood Marrow Transplant; 2002; 8(9):486-92. PubMed ID: 12374453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
    Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
    Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
    Villalón L; Odriozola J; Laraña JG; Zamora C; Pérez de Oteyza J; Jodra MH; López J; Herrera P; Roldán E; Ramos ML; Ramos P; Navarro JL
    Hematol J; 2000; 1(6):374-81. PubMed ID: 11920217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?
    Ener RA; Meglathery SB; Cuhaci B; Topolsky D; Styler MJ; Crilley P; Brodsky I; Kahn SB; King RS
    Am J Clin Oncol; 2001 Feb; 24(1):19-25. PubMed ID: 11232944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation.
    Aljitawi OS; Paul S; Ganguly A; Lin TL; Ganguly S; Vielhauer G; Capitano ML; Cantilena A; Lipe B; Mahnken JD; Wise A; Berry A; Singh AK; Shune L; Lominska C; Abhyankar S; Allin D; Laughlin M; McGuirk JP; Broxmeyer HE
    Blood; 2016 Dec; 128(25):3000-3010. PubMed ID: 27760758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
    Damon L; Rugo H; Tolaney S; Navarro W; Martin T; Ries C; Case D; Ault K; Linker C
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.